Inhibitors of histone deacetylase

Details for Australian Patent Application No. 2004276337 (hide)

Owner Methylgene, Inc.

Inventors Mallais, Tammy C.; Frechette, Sylvie; Moradei, Oscar; Besterman, Jeffrey M.; Tessier, Pierre; Paquin, Isabelle; Vaisburg, Arkadii; Leit, Silvana

Agent Spruson & Ferguson

Pub. Number AU-B-2004276337

PCT Pub. Number WO2005/030705

Priority 60/561,082 09.04.04 US; 60/505,884 24.09.03 US; 60/532,973 29.12.03 US

Filing date 24 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 12 November 2009

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07C 233/25 (2006.01) Carboxylic acid amides

C07C 235/58 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 237/20 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 237/40 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07C 255/60 (2006.01) Carboxylic acid nitriles

C07C 323/42 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 207/325 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/327 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/335 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/73 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/84 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 249/06 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 263/57 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/28 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/30 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/36 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/40 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/54 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030705 Priority application(s): WO2005/030705

12 November 2009 Application Accepted

  Published as AU-B-2004276337

11 March 2010 Standard Patent Sealed

19 May 2011 Assignment Registered

  Methylgene, Inc. The patent has been assigned to MethylGene Inc. Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276341-Pyrazolopyrrole derivatives as protein kinase inhibitors

2004276334-Antisense compound and method for selectively killing activated T cells